OP21 ABX464 is safe and efficacious in a proof-of-concept study in ulcerative colitis patients
2019 ◽
Vol 13
(Supplement_1)
◽
pp. S014-S015
◽
2015 ◽
Vol 9
(suppl 1)
◽
pp. S39-S39
◽
2016 ◽
Vol 10
(suppl 1)
◽
pp. S285.2-S286
Keyword(s):
2017 ◽
Vol 11
(suppl_1)
◽
pp. S390-S391
◽
Keyword(s):
2019 ◽